Table 2 Detection of some human and non-human Influenza A strains by the QIAstat-Dx Respiratory SARS-CoV-2 Panel.

From: Detecting zoonotic Influenza A using QIAstat-Dx Respiratory SARS-CoV-2 panel for pandemic preparedness

Type

Name (serotype)

ID (supplier)

Concentration tested

QIAstat-Dx generic Influenza A Ct (SD)

QIAstat-Dx Influenza A H1 Subtype Ct (SD)

QIAstat-Dx Influenza A H3 Subtype Ct (SD)

QIAstat-Dx Influenza A H1N1pdm09 subtype Ct (SD)

H1N1 subtype

A/Denver/1/57

VR-546 (ATCC

3.4E + 03 CEID50/mL

33.5 (0.2)

33.1 (0.8)

Neg

Neg

3.4E + 02 CEID50/mL

36.1 (0.1)

36.8 (1.0)

Neg

Neg

A/Mal/302/54

VR-98 (ATCC)

1.6E + 02 CEID50/mL

32.3 (0.8)

30.9 (0.2)

Neg

Neg

1.6E + 01 CEID50/mL

35.2 (0.2)

34.4 (0.5)

Neg

Neg

A/Weiss/43

VR-96 (ATCC)

2.8E + 04 CEID50/mL

37.1 (0.8)

38.0 (0.3)

Neg

Neg

2.8E + 03 CEID50/mL

37.9 (0.2)

38.0 (0.3)

Neg

Neg

A/PR/8/34

VR-1469 (ATCC)

3.9E + 02 PFU/mL

34.4 (0.8)

33.7 (0.1)

Neg

Neg

3.9E + 01 PFU/mL

37.7 (0.12)

37.5 (0.9)

Neg

Neg

A/Fort Monmouth/1/1947

VR-1754 (ATCC)

2.8E + 03 CEID50/mL

32.6 (1.0)

31.5 (0.6)

Neg

Neg

2.8E + 02 CEID50/mL

36.6 (1.1)

37.2 (0.6)

Neg

Neg

A/WS/33

VR-1520

1.6E + 02 TCID50/mL

34.1 (0.5)

33.3 (0.5)

Neg

Neg

1.6E + 01 TCID50/mL

37.2 (0.6)

36.8 (0.8)

Neg

Neg

A/Swine/Iowa/15/1930

VR-333 (ATCC)

8.9E + 03 CEID50/mL

32.1 (0.9)

30.8 (1.2)

Neg

Neg

8.9E + 02 CEID50/mL

35.2 (1.0)

34.6 (0.4)

Neg

Neg

H3N2 subtype

A/Wisconsin/15/2009

VR-1882 (ATCC)

5.8E + 01 CEID50/mL

33.3 (0.5)

Neg

32.5 (0.7)

Neg

5.8 E + 00 CEID50/mL

36.2 (0.5)

Neg

37.0 (0.7)

Neg

A/Victoria/3/75

VR-822 (ATCC)

1.6E + 02 CEID50/mL

32.8 (0.1)

Neg

32.7 (0.2)

Neg

1.6E + 01 CEID50/mL

36.8 (1.1)

Neg

35.8 (1.0)

Neg

A/Aichi/2/68

VR-1680 (ATCC)

3.1E + 01 PFU/mL

32.7 (0.3)

Neg

35.0 (0.6)

Neg

3.1E + 00 PFU/mL

34.9 (0.4)

Neg

35.4 (0.8)

Neg

A/Alice (recombinant, carries A/England/42/72)

VR-776 (ATCC)

5.0E + 03 TCID50/mL

32.4 (1.9)

Neg

30.3 (2.1)

Neg

5.0 E + 02 TCID50/mL

34.5 (0.8)

Neg

32.6 (0.6)

Neg

MRC-2 (recombinant A/England/42/72 and A/PR/8/34 strains)

VR-777 (ATCC)

8.9E + 03 CEID50/mL

31.7 (0.6)

Neg

29.6 (0.5)

Neg

8.9E + 02 CEID50/mL

37.0 (1.0)

Neg

33.8 (0.7)

Neg

A/Switzerland/9,715,293/2013

VR-1837 (ATCC)

1.0E + 04 CEID50/mL

32.0 (1.3)

Neg

29.1 (1.1)

Neg

1.0E + 03 CEID50/mL

36.1 (1.6)

Neg

33.8 (1.6)

Neg

H1N1pdm09 subtype

A/Virginia/ATCC2/2009

VR-1737 (ATCC)

6.1E + 01 PFU/mL

35.5 (2.4)

Neg

Neg

35.0 (1.4)

6.1E + 00 PFU/mL

Neg

Neg

Neg

Neg

A/Virginia/ATCC3/2009

VR-1738 (ATCC)

1.8E + 03 PFU/mL

29.0 (1.5)

Neg

Neg

29.3 (1.7)

1.8E + 02 PFU/mL

35.6 (1.9)

Neg

Neg

33.7 (0.5)

A/Swine NY/02/2009

0810109CFNHI (Zeptometrix)

1.4E + 01 TCID50/mL

29.9 (0.9)

Neg

Neg

29.2 (0.8)

1.4E + 00 TCID50/mL

32.2 (0.7)

Neg

Neg

31.5 (0.9)

A/California/07/2009 NYMC X-179A

VR-1884 (ATCC)

1.4E + 04 CEID50/mL

31.9 (1.3)

Neg

Neg

31.0 (1.4)

1.4E + 03 CEID50/mL

36.9 (0.9)

Neg

Neg

37.0 (1.5)

A/Canada/6294/09

0810109CFJHI (Zeptometrix)

1.7E + 01 TCID50/mL

29.4 (0.2)

Neg

Neg

28.7 (0.2)

1.7E + 00 TCID50/mL

32.7 (1.3)

Neg

Neg

32.2 (1.0)

A/Netherlands/2629/2009

NR-19823 (ATCC)

1.6E + 02 TCID50/mL

30.4 (0.5)

Neg

Neg

30.2 (0.2)

1.6E + 01 TCID50/mL

34.5 (0.9)

Neg

Neg

34.5 (1.2)

Non-human Flu A

A/Japan/305/1957 (H2N2)

NR-2775 (ATCC)

3.3E-03 ng/µL

34.7 (0.8)

Neg

Neg

Neg

3.3E-04 ng/µL

37.8 (n/a)

Neg

Neg

Neg

A/Korea/426/1968xPuerto Rico/8/1934 (H2N2)

NR-9679 (ATCC)

6.3E-03 ng/µL

33.5 (1.2)

Neg

Neg

Neg

6.3E-04 ng/µL

36.1 (1.4)

Neg

Neg

Neg

A/Duck/Singapore/645/1997 (H5N3)

NR-9682 (ATCC)

2.5E-03 ng/µL

33.1 (0.9)

Neg

Neg

Neg

2.5E-04 ng/µL

34.5 (0.8)

Neg

Neg

Neg

A/Chicken/Germany/N/49 (H10N7)

NR-2765 (ATCC)

6.8E-03 ng/µL

32.3 (1.4)

Neg

Neg

Neg

6.8E-04 ng/µL

37.0 (0.4)

Neg

Neg

Neg

  1. SD = Standard Deviation. See Supplementary file 3 for further details on QIAstat-Dx Respiratory SARS-CoV-2 cartridges.